We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diffraction Phase Microscopy Reveals Mechanics of Erythrocyte Membranes

By LabMedica International staff writers
Posted on 29 Apr 2010
A novel measurement technique called diffraction phase microscopy uses two beams of light in contrast to other microscopes that only use one.

Using diffraction phase microscopy a team of scientists developed a model that could lead to breakthroughs in screening and treatment of blood-cell-morphology diseases, such as malaria, sickle-cell disease, and spherocytosis. More...
It could also be used to screen banked blood for membrane flexibility before transfusion, since stored blood often undergoes cellular shape changes.

In circulation, erythrocytes or red blood cells (RBCs) must contort to squeeze through capillaries half their diameter. Their flexibility and resilience come from their membrane structure, which couples a typical lipid bilayer with an underlying matrix of protein. However, knowledge of the membrane's mechanics is very limited.

Prof. Gabriel Popescu of the electrical and computer engineering department at the University of Illinois at Urbana Champaign (Champaign, IL, USA) and colleagues were able to see nanoscale membrane fluctuations in live cells, and to measure them quantitatively. The group published its findings in the April 13, 2010 publication of the Proceedings of the [U.S.] National Academy of Sciences (PNAS).

In addition to normal cells, the team also measured two other morphologies: bumpy RBCs called echinocytes and round ones called spherocytes. They discovered that these deformed cells display less flexibility in their membranes, a finding that could provide insight into mechanics and treatment of diseases.

Because diffraction phase microscopy measures live cells without physically manipulating or damaging them, it also could be used to evaluate medications being developed to treat blood cell morphology diseases, according to Prof. Popescu. "We can study the mechanics of a single cell under different pharmacological conditions, and I think that would be ideal for testing drugs," he said.

Related Links:
University of Illinois at Urbana Champaign



New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.